Contra Costa Health Services
Martinez, California, 94553, United States
NCT Number: NCT06300242
In this work, we are assessing the impact of messaging with or without a $50 financial incentive on influenza vaccination rates in a county health system. Our main hypothesis is that a message with a $50 financial incentive will increase vaccination rates relative to a control/"treatment as usual" group. We further hypothesize that the financial incentive will increase vaccination rates relative to the message only arm.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Martinez, California, 94553, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Reminders
$50 financial incentive for getting vaccinated within 1-week
No special messages or incentives
Time frame: 1 week
influenza vaccination status as documented in the EMR and from the California Immunization Registry (CAIRS)
Time frame: 2 weeks
Influenza vaccination status as documented in the EMR and from the California Immunization Registry (CAIRS)
Time frame: 1 month
Influenza vaccination status as documented in the EMR and from the California Immunization Registry (CAIRS)
University of Southern California
Other
Financial Incentives for Influenza Vaccination
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06850051
Healthy Volunteers, Human Metapneumovirus Vaccination
Blacktown, New South Wales, Australia
View Trial DetailsNCT07231016
Communicable Diseases, Disease Attributes
Taipei, Taiwan
View Trial DetailsNCT05479370
Infections, Influenza Vaccination
Singapore
View Trial DetailsNCT05785078
Infections, Influenza Vaccination
Rome, RM, Italy
View Trial Details